<<
>>

THERAPEUTICS

There have been no published drug pharmacokinetic studies in dasyurids and drug doses are frequently extrapolated from domestic dogs and cats. Cefovecin (Convenia®, Zoetis, West Ryde, NSW) has been used to treat bacterial infections in Tasmanian devils at the dose rate of 8 mg/kg with the assumption that it has a similar duration of action (up to 7 d) as in dogs and cats.

How­ever, in vitro studies of cefovecin plasma protein binding in several marsupial species, including the Tasmanian devil, have shown it is between 12% and 40%, suggesting duration of action is likely to be much shorter in these species (S Gharibi pers. comm., see Chapter 11). Conges­tive heart failure, often secondary to bradyarrhythmia in Tasmanian devils, has been managed using frusemide ± pimobendan (M Campbell-Ward pers. comm.). Analgesic options for managing animals with degenerative joint disease include meloxicam or carprofen (see Appendix 4). A range of medications have been used for external and internal parasite control, including fipronil, selamectin, spinosad, and emodepside in combination with praziqu­antel (Profender® Spot On, Bayer Australia, Pymble, NSW) using domestic species’ dose rates.

Chemotherapeutic agents have been trialled in Tasma­nian devils in an effort to treat DFTD (see Chapters 11 and 40).

6.

<< | >>
Source: Vogelnest L., Portas T. (Eds.). Current Therapy in Medicine of Australian Mammals. CSIRO,2025. — 848 p.. 2025

More on the topic THERAPEUTICS: